Synchronous percutaneous core-needle biopsy and microwave ablation for stage I non-small cell lung cancer in patients with Idiopathic pulmonary fibrosis: initial experience

References

• Tzouvelekis A, Gomatou G, Bouros E, et al. Common pathogenic mechanisms between idiopathic pulmonary fibrosis and lung cancer. Chest. 2019;156(2):383–391. doi: 10.1016/j.chest.2019.04.114.
   PubMed Web of Science ®Google Scholar
• Tran T, Šterclová M, Mogulkoc N, et al. The european MultiPartner IPF registry (EMPIRE): validating long-term prognostic factors in idiopathic pulmonary fibrosis. Respir Res. 2020;21(1):11. doi: 10.1186/s12931-019-1271-z.
   PubMed Web of Science ®Google Scholar
• Harari S, Caminati A. IPF: new insight on pathogenesis and treatment. Allergy. 2010;65(5):537–553. doi: 10.1111/j.1398-9995.2009.02305.x.
   PubMed Web of Science ®Google Scholar
• Ballester B, Milara J, Cortijo J. Idiopathic pulmonary fibrosis and lung cancer: mechanisms and molecular targets. Int J Mol Sci. 2019;20(3):593. doi: 10.3390/ijms20030593.
   PubMed Web of Science ®Google Scholar
• Samarelli AV, Masciale V, Aramini B, et al. Molecular mechanisms and cellular contribution from lung fibrosis to lung cancer development. Int J Mol Sci. 2021;22(22):12179. doi: 10.3390/ijms222212179.
   PubMed Web of Science ®Google Scholar
• Phan THG, Paliogiannis P, Nasrallah GK, et al. Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis. Cell Mol Life Sci. 2021;78(5):2031–2057. doi: 10.1007/s00018-020-03693-7.
   PubMed Web of Science ®Google Scholar
• Ettinger DS, Wood DE, Aisner DL, et al. Non-Small cell lung cancer, version 3.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022;20(5):497–530. doi: 10.6004/jnccn.2022.0025.
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Yano Y, Kuge T, et al. Safety and effectiveness of pirfenidone combined with carboplatin-based chemotherapy in patients with idiopathic pulmonary fibrosis and non-small cell lung cancer: a retrospective cohort study. Thorac Cancer. 2020;11(11):3317–3325. doi: 10.1111/1759-7714.13675.
   PubMed Web of Science ®Google Scholar
• Otsubo K, Kishimoto J, Ando M, et al. Nintedanib plus chemotherapy for nonsmall cell lung cancer with idiopathic pulmonary fibrosis: a randomised phase 3 trial. Eur Respir J. 2022;60(6):2200380. doi: 10.1183/13993003.00380-2022.
   PubMed Web of Science ®Google Scholar
• Makiguchi T, Tanaka H, Okudera K, et al. Safety and feasibility of carboplatin and paclitaxel in combination with nintedanib for non-small cell lung cancer patients with idiopathic pulmonary fibrosis: a prospective pilot study. Transl Lung Cancer Res. 2023;12(4):719–726. doi: 10.21037/tlcr-22-699.
   PubMedGoogle Scholar
• Zhang M, Fan Y, Nie L, et al. Clinical outcomes of immune checkpoint inhibitor therapy in patients with advanced non-small cell lung cancer and preexisting interstitial lung diseases: a systematic review and meta-analysis. Chest. 2022;161(6):1675–1686. doi: 10.1016/j.chest.2021.12.656.
   PubMed Web of Science ®Google Scholar
• Iyoda A, Azuma Y, Sakamoto S, et al. Surgical treatment for patients with idiopathic pulmonary fibrosis and lung cancer: postoperative acute exacerbation of idiopathic pulmonary fibrosis and outcomes. Surg Today. 2022;52(5):736–744. doi: 10.1007/s00595-021-02343-0.
   PubMed Web of Science ®Google Scholar
• Chan MV, Huo YR, Cao C, et al. Survival outcomes for surgical resection versus CT-guided percutaneous ablation for stage I non-small cell lung cancer (NSCLC): a systematic review and meta-analysis. Eur Radiol. 2021;31(7):5421–5433. doi: 10.1007/s00330-020-07634-7.
   PubMed Web of Science ®Google Scholar
• Kong F, Bie Z, Li Y, et al. Synchronous microwave ablation followed by core-needle biopsy via a coaxial cannula for highly suspected malignant lung ground-glass opacities: a single-center, single-arm retrospective study. Thorac Cancer. 2021;12(23):3216–3222. doi: 10.1111/1759-7714.14189.
   PubMed Web of Science ®Google Scholar
• Xu S, Qi J, Li B, et al. Survival prediction for non-small cell lung cancer patients treated with CT-guided microwave ablation: development of a prognostic nomogram. Int J Hyperthermia. 2021;38(1):640–649. doi: 10.1080/02656736.2021.1914353.
   PubMed Web of Science ®Google Scholar
• Ni Y, Huang G, Yang X, et al. Microwave ablation treatment for medically inoperable stage I non-small cell lung cancers: long-term results. Eur Radiol. 2022;32(8):5616–5622. doi: 10.1007/s00330-022-08615-8.
   PubMed Web of Science ®Google Scholar
• Okuma T, Tsuji T, Sakamoto T, et al. A case of postoperative pyopneumothorax following CT-guided radiofrequency ablation for lung cancer with interstitial pneumonia. Acta Radiol Short Rep. 2012;1(5):arsr.2012.110014. doi: 10.1258/arsr.2012.110014.
   PubMedGoogle Scholar
• Li B, Bie ZX, Li YM, et al. Percutaneous biopsy and synchronously microwave ablation for treating early-stage non-small cell lung cancer complicated with diffuse pulmonary interstitial fibrosis: case report. Chin J Interv Imaging Ther. 2022;19(12):799.
   Google Scholar
• Aufranc V, Farouil G, Abdel-Rehim M, et al. Percutaneous thermal ablation of primary and secondary lung tumors: comparison between microwave and radiofrequency ablation. Diagn Interv Imaging. 2019;100(12):781–791. doi: 10.1016/j.diii.2019.07.008.
   PubMed Web of Science ®Google Scholar
• Brace CL. Microwave ablation technology: what every user should know. Curr Probl Diagn Radiol. 2009;38(2):61–67. doi: 10.1067/j.cpradiol.2007.08.011.
   PubMedGoogle Scholar
• Moynagh MR, Dowdy SC, Welch B, et al. Image-guided tumor ablation in gynecologic oncology: review of interventional oncology techniques and case examples highlighting a collaborative, multidisciplinary program. Gynecol Oncol. 2021;160(3):835–843. doi: 10.1016/j.ygyno.2020.12.037.
   PubMed Web of Science ®Google Scholar
• Genshaft SJ, Suh RD, Abtin F, et al. Society of interventional radiology quality improvement standards on percutaneous ablation of Non-Small cell lung cancer and metastatic disease to the lungs. J Vasc Interv Radiol. 2021;32(8):1242.e1–1242.e10. doi: 10.1016/j.jvir.2021.04.027.
   PubMed Web of Science ®Google Scholar
• Murphy MC, Wrobel MM, Fisher DA, et al. Update on Image-Guided thermal lung ablation: society guidelines, therapeutic alternatives, and postablation imaging findings. AJR Am J Roentgenol. 2022;219(3):471–485. doi: 10.2214/AJR.21.27099.
   PubMed Web of Science ®Google Scholar
• Puijk RS, Ahmed M, Adam A, et al. Consensus guidelines for the definition of time-to-Event end points in image-guided tumor ablation: results of the SIO and DATECAN initiative. Radiology. 2021;301(3):533–540. doi: 10.1148/radiol.2021203715.
   PubMed Web of Science ®Google Scholar
• Ye X, Fan W, Wang Z, et al. Clinical practice guidelines on image-guided thermal ablation of primary and metastatic lung tumors (2022 edition). J Cancer Res Ther. 2022;18(5):1213–1230. doi: 10.4103/jcrt.jcrt_880_22.
   PubMed Web of Science ®Google Scholar
• Rose SC, Dupuy DE, Gervais DA, et al. Research reporting standards for percutaneous thermal ablation of lung neoplasms. J Vasc Interv Radiol. 2009;20(7 Suppl):S474–S485. doi: 10.1016/j.jvir.2009.01.016.
   PubMed Web of Science ®Google Scholar
• Hess A, Palussière J, Goyers JF, et al. Pulmonary radiofrequency ablation in patients with a single lung: feasibility, efficacy, and tolerance. Radiology. 2011;258(2):635–642. doi: 10.1148/radiol.10100771.
   PubMed Web of Science ®Google Scholar
• Yang X, Ye X, Zhang L, et al. Microwave ablation for lung cancer patients with a single lung: clinical evaluation of 11 cases. Thorac Cancer. 2018;9(5):548–554. doi: 10.1111/1759-7714.12611.
   PubMed Web of Science ®Google Scholar
• Peng J, Bie Z, Li Y, et al. Microwave ablation of lung malignancies with coexisting severe emphysema: a retrospective analysis of safety and efficacy in 26 patients. Int J Hyperthermia. 2021;38(1):136–143. doi: 10.1080/02656736.2021.1876254.
   PubMed Web of Science ®Google Scholar
• Shin YJ, Yun G, Yoon SH, et al. Accuracy and complications of percutaneous transthoracic needle lung biopsy for the diagnosis of malignancy in patients with idiopathic pulmonary fibrosis. Eur Radiol. 2021;31(12):9000–9011. doi: 10.1007/s00330-021-08038-x.
   PubMed Web of Science ®Google Scholar
• Han X, Yang X, Huang G, et al. Safety and clinical outcomes of computed tomography-guided percutaneous microwave ablation in patients aged 80 years and older with early-stage non-small cell lung cancer: a multicenter retrospective study. Thorac Cancer. 2019;10(12):2236–2242. doi: 10.1111/1759-7714.13209.
   PubMed Web of Science ®Google Scholar
• Healey TT, March BT, Baird G, et al. Microwave ablation for lung neoplasms: a retrospective analysis of long-term results. J Vasc Interv Radiol. 2017;28(2):206–211. doi: 10.1016/j.jvir.2016.10.030.
   PubMed Web of Science ®Google Scholar
• Belfiore G, Ronza F, Belfiore MP, et al. Patients’ survival in lung malignancies treated by microwave ablation: our experience on 56 patients. Eur J Radiol. 2013;82(1):177–181. doi: 10.1016/j.ejrad.2012.08.024.
   PubMed Web of Science ®Google Scholar
• Peng J, Bie Z, Su F, et al. Effects of tract embolization on pneumothorax rate after percutaneous pulmonary microwave ablation: a rabbit study. Int J Hyperthermia. 2023;40(1):2165728.
   PubMed Web of Science ®Google Scholar
• Okuma T, Matsuoka T, Hamamoto S, et al. Percutaneous computed tomography-guided radiofrequency ablation of lung tumors complicated with idiopathic interstitial pneumonia. Ann Thorac Surg. 2009;87(3):948–950. doi: 10.1016/j.athoracsur.2008.07.069.
   PubMed Web of Science ®Google Scholar